Allogeneic MHC Class I Molecules With Numerous Sequence Differences Do Not Elicit a CTL Response

• Published in: Human Immunology 2005-09, Vol.66 (9), p.969-976
• Main Authors: Heemskerk, Martin B.A., Roelen, Dave L., Dankers, Marlies K.A., van Rood, Jon J., Claas, Frans H.J., Doxiadis, Ilias I.N., Oudshoorn, Machteld
• Format: Article
• Language: English
• Subjects: allogeneic CTL response; Amino Acid Substitution; Base Pair Mismatch; CTLp assay; Cytotoxicity Tests, Immunologic; haematopoietic stem cell transplantation; Hematopoietic Stem Cell Transplantation; Histocompatibility Antigens Class I - chemistry; Humans; MHC class I; Retrospective Studies; T-Lymphocytes, Cytotoxic - immunology; Transplantation, Homologous
• ISSN: 0198-8859; 1879-1166; 1365-2567
• DOI: 10.1016/j.humimm.2005.06.007

CD8+ T cell-mediated alloreactivity is generally believed to involve recognition of the α1/α2 domains of donor-type class I MHC molecules as well as the peptides they bind. Using the CTLp assay outcome as a parameter for the induction of alloreactivity, we have retrospectively surveyed 80 haematopoietic stem cell donor/patient pairs that feature a range of allelic differences at single HLA-A, -B, and -C loci in an attempt to probe the predictive value of such mismatches. In contrast to the expectation that greater degree of allelic disparity would lead to more alloreactivity, we found that in a substantial number of cases, class I MHC molecules with numerous sequence differences did not elicit an allogeneic CTL response. We propose that in generating a T cell repertoire with a sufficiently narrow responsive for self-MHC, positive thymic selection limits the capacity to recognize allogeneic MHC molecules whose structure and sequence have diverged extensively. These findings are important for donor and patient MHC matching strategies and our understanding of T cell-MHC interaction after haematopoietic stem cell transplantation.